| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/23/2023 | 6.02% | Wedbush | $27 → $37 | Maintains | Neutral |
| 02/02/2023 | 0.29% | Piper Sandler | $26 → $35 | Maintains | Neutral |
| 07/28/2022 | 8.88% | UBS | $40 → $38 | Maintains | Neutral |
| 06/14/2022 | 14.61% | Piper Sandler | $49 → $40 | Maintains | Neutral |
| 04/21/2022 | 40.4% | Piper Sandler | $62 → $49 | Downgrades | Overweight → Neutral |
| 04/18/2022 | 28.94% | B of A Securities | $55 → $45 | Maintains | Underperform |
| 04/07/2022 | 77.65% | Piper Sandler | $75 → $62 | Maintains | Overweight |
| 03/28/2022 | 54.73% | Wedbush | → $54 | Downgrades | Outperform → Neutral |
| 02/24/2022 | 86.25% | UBS | $80 → $65 | Maintains | Neutral |
| 02/04/2022 | 152.15% | Wedbush | $85 → $88 | Upgrades | Neutral → Outperform |
| 02/18/2021 | 372.78% | Piper Sandler | $108 → $165 | Maintains | Overweight |
| 02/10/2021 | 243.84% | Wedbush | $52 → $120 | Maintains | Neutral |
| 02/04/2021 | 152.15% | B of A Securities | → $88 | Downgrades | Neutral → Underperform |
| 11/17/2020 | 109.17% | B of A Securities | → $73 | Upgrades | Underperform → Neutral |
| 10/15/2020 | 26.07% | B of A Securities | $31 → $44 | Maintains | Underperform |
| 07/10/2020 | 86.25% | Piper Sandler | $39 → $65 | Upgrades | Neutral → Overweight |
| 04/23/2020 | -16.91% | Piper Sandler | $28 → $29 | Maintains | Neutral |
| 04/15/2020 | -19.77% | Piper Sandler | $62 → $28 | Maintains | Neutral |
| 04/13/2020 | -14.04% | Wedbush | $25 → $30 | Maintains | Neutral |
| 03/30/2020 | -48.42% | UBS | $34 → $18 | Maintains | Sell |
| 03/25/2020 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 02/20/2020 | 69.05% | Wedbush | $45 → $59 | Maintains | Neutral |
| 02/20/2020 | -5.44% | B of A Securities | $30 → $33 | Reiterates | → Underperform |
| 02/20/2020 | -2.58% | UBS | $31 → $34 | Maintains | Sell |
| 02/20/2020 | 77.65% | Raymond James | $54 → $62 | Maintains | Outperform |
| 10/16/2019 | -16.91% | UBS | $27 → $29 | Maintains | Sell |
| 10/16/2019 | 40.4% | Piper Sandler | $43 → $49 | Maintains | Neutral |
| 10/16/2019 | 28.94% | Wedbush | $44 → $45 | Maintains | Neutral |
| 10/09/2019 | 37.54% | Raymond James | → $48 | Upgrades | Market Perform → Outperform |
| 09/23/2019 | -14.04% | B of A Securities | $34 → $30 | Maintains | Underperform |
| 01/28/2019 | 3.15% | Barclays | → $36 | Initiates Coverage On | → Equal-Weight |
| 07/26/2018 | 20.34% | Stifel | $47 → $42 | Maintains | Buy |
| 07/26/2018 | — | Piper Sandler | Downgrades | Overweight → Neutral | |
| 04/19/2018 | -28.37% | B of A Securities | $27 → $25 | Maintains | Underperform |
| 04/19/2018 | — | Raymond James | Downgrades | Outperform → Market Perform |
What is the target price for Sleep Number (SNBR)?
The latest price target for Sleep Number (NASDAQ: SNBR) was reported by Wedbush on February 23, 2023. The analyst firm set a price target for $37.00 expecting SNBR to rise to within 12 months (a possible 6.02% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Sleep Number (SNBR)?
The latest analyst rating for Sleep Number (NASDAQ: SNBR) was provided by Wedbush, and Sleep Number maintained their neutral rating.
When is the next analyst rating going to be posted or updated for Sleep Number (SNBR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sleep Number, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sleep Number was filed on February 23, 2023 so you should expect the next rating to be made available sometime around February 23, 2024.
Is the Analyst Rating Sleep Number (SNBR) correct?
While ratings are subjective and will change, the latest Sleep Number (SNBR) rating was a maintained with a price target of $27.00 to $37.00. The current price Sleep Number (SNBR) is trading at is $34.90, which is within the analyst's predicted range.